drugset
drugset / Trial / NCT01149460

Valacyclovir 1000 mg Tablet Under Fed Conditions

NCT01149460 ↗

Phase 1 Completed 36 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to compare the rate and extent of absorption of Teva Pharmaceuticals USA valacyclovir and GlaxoSmithKline, USA (Valtrex) valacyclovir, administered as 1 x 1000 mg tablet under fed conditions.

Timeline

Start
2004-09
Primary completion
2004-09
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Valacyclovir Unknown 1000 mg —

Indications

No indication recorded.